...
首页> 外文期刊>Iranian Journal of Immunology >Immunotherapy of Chenopodium Album Induced Asthma by Intranasal Administration of CpG Oligodeoxynucleotides in BALB/c Mice
【24h】

Immunotherapy of Chenopodium Album Induced Asthma by Intranasal Administration of CpG Oligodeoxynucleotides in BALB/c Mice

机译:经鼻内施用CpG寡脱氧核苷酸在BALB / c小鼠中对藜属蛋白诱导的哮喘进行免疫治疗

获取原文
           

摘要

Background: There are many therapeutic methods for allergic conditions. CpG oli-gonucleotides play a critical role in immunity via the augmentation of Th1 and suppres-sion of Th2 responses. Objective: In the present study we aimed to estimate the effec-tiveness of intranasal administration of CpG ODN plus Chenopodium album allergen in allergic asthma compared with the administration of allergen alone and to find out how CpG ODN therapy is useful in the treatment of allergen induced asthma. Methods: BALB/c Mice were intraperitoneally and intranasally sensitized with allergenic extract precipitated on aluminum hydroxide. Therapy with CpG/Ag was performed intrana-sally. After antigenic challenge, a number of Immunologic variables such as serum IgE and IgG, systemic and local IL-10 and IFN-γ were studied in splenocytes, and lung tis-sue culture supernatants, respectively. Results: Our study indicated that intranasal ad-ministration of CpG/Ag had significant increases in both systemic and local levels of IL-10 and IFN-γ (p≤ 0.001), but showed no significant effect on the levels of IgE, IgG2a, and IgG1 in serum (p= 0.06). This study demonstrated that CpG ODN has thera-peutic effects not only on splenocytes but also on nasal lymphocytes to produce IFN-γ as a Th1 cytokine, and IL-10 as a regulatory cytokine. Conclusion: According to these data from the mouse model, we conclude that intranasal administration of CpG motifs before allergen exposure may be useful for the control of allergic asthma. Therefore, further investigations on humans using CpG motifs are recommended in order to modu-late the allergic effects of Chenopodium album as well as other regional allergens.
机译:背景:过敏性疾病的治疗方法很多。 CpG寡核苷酸通过增加Th1和抑制Th2反应在免疫中起关键作用。目的:在本研究中,我们旨在评估与单独使用过敏原相比,鼻内施用CpG ODN和藜芦白蛋白过敏原在过敏性哮喘中的疗效,并探讨CpG ODN疗法如何用于治疗过敏原哮喘。方法:将BALB / c小鼠腹腔和鼻内用沉淀在氢氧化铝上的致敏提取物致敏。鼻内用CpG / Ag进行治疗。抗原攻击后,分别在脾细胞和肺组织培养上清液中研究了许多免疫学变量,例如血清IgE和IgG,全身和局部IL-10和IFN-γ。结果:我们的研究表明,鼻内CpG / Ag的全身和局部IL-10和IFN-γ水平均显着升高(p≤0.001),但对IgE,IgG2a,和血清中的IgG1(p = 0.06)。这项研究表明,CpG ODN不仅对脾细胞具有治疗作用,而且对鼻淋巴细胞也具有治疗作用,产生IFN-γ作为Th1细胞因子,产生IL-10作为调节细胞因子。结论:根据来自小鼠模型的这些数据,我们得出结论,在过敏原暴露之前经鼻内施用CpG基序可能对控制过敏性哮喘有用。因此,建议进一步研究使用CpG基序的人类,以调节藜芦蛋白以及其他区域性过敏原的过敏作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号